UNIVERSITY OF KENTUCKY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1865-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uky.edu
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Phase 1
Completed
- Conditions
- Breast CancerLeukemiaLymphomaNeuroblastomaOvarian CancerSarcomaUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Biological: filgrastimProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2004-02-20
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 25
- Registration Number
- NCT00003425
- Locations
- 🇺🇸
Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, United States
🇺🇸Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States